Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB00998_nanopub.RAL3D_RMmz5l0KibC5I5-rvOjfRB3oflcnnJHd2nP1kAU#assertion>. }
Showing items 1 to 24 of
24
with 100 items per page.
- drugbank:DB00998 type drugbank_vocabulary:Drug assertion.
- drugbank:DB00998 label "Frovatriptan [drugbank:DB00998]" assertion.
- drugbank:DB00998 seeAlso DB00998 assertion.
- drugbank:DB00998 seeAlso frovatriptan.html assertion.
- drugbank:DB00998 seeAlso fro1622.shtml assertion.
- drugbank:DB00998 seeAlso frova.htm assertion.
- drugbank:DB00998 identifier "drugbank:DB00998" assertion.
- drugbank:DB00998 description "Frovatriptan (Frova®) is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe.[1] Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2.5 mg tablets. Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than other triptans. Frovatriptan is available only by prescription in the United States, where a secondary New Drug Approval (sNDA) was filed in July 2006[2] and which is currently pending.[3] The FDA anticipates completing its review of this application on or before the current PDUFA (Prescription Drug User Fee Act) review date of August 19, 2007. If the sNDA is approved, Frova® will be the only medication indicated in the U.S. for the short-term prevention of menstrual migraine (MM)." assertion.
- drugbank:DB00998 title "Frovatriptan" assertion.
- drugbank:DB00998 bio2rdf_vocabulary:identifier "DB00998" assertion.
- drugbank:DB00998 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB00998 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB00998" assertion.
- drugbank:DB00998 bio2rdf_vocabulary:x-identifiers.org DB00998 assertion.
- drugbank:DB00998 drugbank_vocabulary:drugbank-id "APRD00270" assertion.
- drugbank:DB00998 drugbank_vocabulary:drugbank-id "DB00998" assertion.
- drugbank:DB00998 drugbank_vocabulary:x-cas cas:158747-02-5 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-chemspider chemspider:70378 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-pubchemcompound pubchem.compound:77992 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46506288 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-atc atc:N02CC07 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164754891 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-wikipedia wikipedia:Frovatriptan assertion.
- drugbank:DB00998 drugbank_vocabulary:x-bindingdb bindingdb:50073689 assertion.
- drugbank:DB00998 drugbank_vocabulary:x-ndc ndc:63481-025-09 assertion.